Fund Holdings — Caligan Partners LP

Total Portfolio Value
$1.09B
Total Bought
$297.02M
Total Sold
$92.65M
Net Transaction
+$204.37M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
LIQUIDIA CORPORATION(LQDA)8,118,8928,118,8920184,624280,02125.63%+95,397
VAXCYTE INC(PCVX)01,704,815+1,704,815078,6607.20%+78,660
ABIVAX SA(ABVX)1,451,9241,451,9240123,268195,79917.92%+72,531
REVOLUTION MEDICINES INC(RVMD)1,064,2491,283,900+219,65149,700102,2639.36%+52,562
TANGO THERAPEUTICS INC(TNGX)03,729,895+3,729,895033,0473.03%+33,047
MAZE THERAPEUTICS INC(MAZE)0550,191+550,191022,7942.09%+22,794
RAPT THERAPEUTICS INC0644,400+644,400021,8262.00%+21,826
INHIBRX BIOSCIENCES INC(INBX)236,383323,565+87,1827,96125,5622.34%+17,600
ADMA BIOLOGICS INC2,636,6093,012,508+375,89938,65354,9485.03%+16,295
TYRA BIOSCIENCES INC(TYRA)696,825944,257+247,4329,74924,8252.27%+15,076
VOR BIOPHARMA INC(VOR)0925,067+925,06709,9630.91%+9,963
INVENTIVA SA(IVA)02,000,000+2,000,00009,3000.85%+9,300
XENON PHARMACEUTICALS INC(XENE)444,565549,665+105,10017,84924,6362.26%+6,787
AVALO THERAPEUTICS INC(AVTX)833,333881,533+48,20010,59216,0091.47%+5,417
EXELIXIS INC(EXEL)1,525,7301,553,262+27,53263,01368,0796.23%+5,067
VERRICA PHARMACEUTICALS INC(VRCA)923,910923,91003,9827,6780.70%+3,696
SPRUCE BIOSCIENCES INC020,514+20,51401,7870.16%+1,787
ELEDON PHARMACEUTICALS INC(ELDN)0555,978+555,97808400.08%+840
ANIKA THERAPEUTICS INC1,435,1301,435,130013,49013,7921.26%+301
AURA BIOSCIENCES INC(AURA)227,1740-227,1741,4040—-1,404
MINERALYS THERAPEUTICS INC(MLYS)2,772,6542,772,6540105,139100,6209.21%-4,519
MERUS N V216,9540-216,95420,4260—-20,426
EVOLUS INC(EOLS)4,138,9430-4,138,94325,4130—-25,413
AGIOS PHARMACEUTICALS INC(AGIO)1,131,2050-1,131,20545,4070—-45,407
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q4 2025 | TickerTrail